Video Vitals and Biomarkers

The investigators are doing this research to study the ability of mobile devices to measure vital signs and biomarkers from video as compared to standard-of-care clinical office tools.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiometabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

ARCpoint Labs of Cedar Park

Cedar Park, Texas, 78613, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Must be able to stay in a seated position for 30 minutes
Must be able to participate in a venous blood draw

Exclusion criteria

Condition that prevents prolonged seated position
Condition that restricts ability to provide venous blood sample

Treatment and study plan

Primary outcomes

Heart rate in beats per minute

Time frame: 2 minutes
Blood pressure (systolic/diastolic) in millimeters of mercury (mmHg)

Time frame: 2 minutes
Respiration rate in breaths per minute

Time frame: 2 minutes
Oxygen saturation in SpO2 percentage

Time frame: 2 minutes

Sponsors and collaborators

Lead sponsor

Maiv Health Inc.

Industry

Registry information

Official study title

Measuring Vital Signs and Biomarkers From Mobile Device Videos

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Nov 18, 2023
Registry last updated: Sep 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed